Aridis Pharmaceuticals, Inc. Contracts & Agreements

37 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
At-the-Market Sales Agreement, dated January 19, 2022 by and between the Company and Virtu Americas LLC
Sales Agreements
Aridis Pharmaceuticals, Inc.
Biotechnology
NY
2022
Form of Securities Purchase Agreement
Purchase Agreements
Aridis Pharmaceuticals, Inc.
2024
Form of Warrant
Warrant Agreements
Aridis Pharmaceuticals, Inc.
2023
Form of Securities Purchase Agreement
Purchase Agreements
Aridis Pharmaceuticals, Inc.
2023
Form of Warrant
Warrant Agreements
Aridis Pharmaceuticals, Inc.
2023
Form of Pre-Funded Warrant
Warrant Agreements
Aridis Pharmaceuticals, Inc.
2023
Form of Securities Purchase Agreement
Purchase Agreements
Aridis Pharmaceuticals, Inc.
2023
Form of Secured Promissory Note
Note Agreements
Aridis Pharmaceuticals, Inc.
2023
Note Purchase Agreement dated as of April 26, 2023
Note Agreements
Aridis Pharmaceuticals, Inc.
2023
Security Agreement dated as of April 26, 2023
Security Agreements
Aridis Pharmaceuticals, Inc.
2023
Form of Securities Purchase Agreement
Purchase Agreements
Aridis Pharmaceuticals, Inc.
2023
Form of Securities Purchase Agreement
Purchase Agreements
Aridis Pharmaceuticals, Inc.
Biotechnology
CA
2022
Form of Pre-Funded Warrant
Warrant Agreements
Aridis Pharmaceuticals, Inc.
Biotechnology
2022
Form of Warrant
Warrant Agreements
Aridis Pharmaceuticals, Inc.
Biotechnology
2022
Form of Securities Purchase Agreement
Purchase Agreements
Aridis Pharmaceuticals, Inc.
2022
Form of Secured Promissory Note
Note Agreements
Aridis Pharmaceuticals, Inc.
Biotechnology
UT
2021
Note Purchase Agreement dated as of November 23, 2021
Note Agreements
Aridis Pharmaceuticals, Inc.
2021
Security Agreement dated as of November 23, 2021
Security Agreements
Aridis Pharmaceuticals, Inc.
Biotechnology
UT
2021
Amendment No. 1 to the License Agreement between Medimmune Limited and Aridis Pharmaceuticals, Inc. dated August 9, 2021
License Agreements
Aridis Pharmaceuticals, Inc.
2021
Form of Common Stock Purchase Warrant
Warrant Agreements
Aridis Pharmaceuticals, Inc.
Biotechnology
2021
Form of Pre-Funded Common Stock Purchase Warrant
Warrant Agreements
Aridis Pharmaceuticals, Inc.
Biotechnology
2021
Form of Securities Purchase Agreement
Purchase Agreements
Aridis Pharmaceuticals, Inc.
2021
License Agreement between Medimmune Limited and Aridis Pharmaceuticals, Inc. dated as of July 12, 2021
License Agreements
Aridis Pharmaceuticals, Inc.
Biotechnology
NY
2021
Form of Securities Purchase Agreement, dated March 15, 2021, by and between Aridis Pharmaceuticals, Inc. and the Purchasers
Purchase Agreements
Aridis Pharmaceuticals, Inc.
Biotechnology
NY
2021
Exclusive License Agreement dated September 10, 2020 by and between Aridis Pharmaceuticals, Inc. and UAB Research Foundation
License Agreements
Aridis Pharmaceuticals, Inc.
Biotechnology
TX
2020
Office Lease dated October 14, 2020 by and between Aridis Pharmaceuticals, Inc. and Boccardo Corporation
Lease Agreements
Aridis Pharmaceuticals, Inc.
Biotechnology
CA
2020
Form of Securities Purchase Agreement, dated October 13, 2020, by and between Aridis Pharmaceuticals, Inc. and the Purchasers
Purchase Agreements
Aridis Pharmaceuticals, Inc.
2020
Form of Series A Warrant
Warrant Agreements
Aridis Pharmaceuticals, Inc.
Biotechnology
NY
2020
Form of Series B Warrant
Warrant Agreements
Aridis Pharmaceuticals, Inc.
Biotechnology
NY
2020
Description of the Registrant's Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934
Aridis Pharmaceuticals, Inc.
2020
License, Development and Commercialization Agreement between Aridis Pharmaceuticals, Inc. and Serum AMR Products, entered into as of September 27, 2019
License Agreements
Aridis Pharmaceuticals, Inc.
Biotechnology
CA
2019
Option Agreement for Exclusive Product and Platform Technology License between Aridis Pharmaceuticals, Inc. and Serum International BV, dated July 16, 2019
License Agreements
Aridis Pharmaceuticals, Inc.
2019
Stock Subscription Agreement, dated July 19, 2019
Stock Agreements
Aridis Pharmaceuticals, Inc.
2019
Amendment No. 1 to the Agreement between the Registrant and the Cystic Fibrosis Foundation Therapeutics, Inc., effective November 26, 2018
Aridis Pharmaceuticals, Inc.
Biotechnology
2019
Amendment to the Joint Venture Contract in respect of Shenzen Arimab BioPharmaceutical Co., Ltd., by and between Shenzen Hepalink Pharmaceutical Group Co. and the Company,...
Joint Venture Agreements
Aridis Pharmaceuticals, Inc.
2018
Amended and Restated Technology License and Collaboration Agreement, by and between Shenzen Arimab BioPharmaceutical Co., Ltd. and the Company, effective August 6, 2018
Collaboration Agreements
Aridis Pharmaceuticals, Inc.
2018
Aridis Pharmaceuticals, Inc. [] Shares Common Stock (par value $0.001 per share) Underwriting Agreement
Underwriting Agreements
Aridis Pharmaceuticals, Inc.
2018